b -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease

School of Psychology, Psychiatry and Psychological Medicine, Monash University, Melbourne, Department of Nuclear Medicine, Centre for PET, Austin Health, Heidelberg, Centre for Neurosciences, University of Melbourne, The Mental Health Research Institute, Parkville, Cogstate Pty Ltd, Melbourne,Victoria, Australia, Departments of Radiology and Psychiatry,University of Pittsburgh, PA,USA and Department of Medicine, Austin Health,University of Melbourne,Victoria, Australia Present address: Macquarie Centre for Cognitive Science (MACCS), Macquarie University, Sydney, NSW, Australia

[1]  L. Squire,et al.  Structure and function of declarative and nondeclarative memory systems. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Mesulam,et al.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. , 2003, Archives of neurology.

[3]  Gina N. LaRossa,et al.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.

[4]        Global prevalence of dementia: a Delphi consensus study , 2006 .

[5]  Brian J Cummings,et al.  β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease , 1996, Neurobiology of Aging.

[6]  P. Scheltens,et al.  Advances in the early detection of Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[7]  J. Morrison,et al.  Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer’s disease , 2002, Neuroscience.

[8]  J. Sinacore Multiple regression: Testing and interpreting interactions , 1993 .

[9]  D. Balota,et al.  Relating anatomy to function in Alzheimer's disease , 1998, Neurology.

[10]  Correlation of Entorhinal Amyloid with Memory in Alzheimer’s and Vascular but Not Lewy Body Dementia , 2005, Dementia and Geriatric Cognitive Disorders.

[11]  G. E. Alexander,et al.  Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment , 2006, Neurobiology of Aging.

[12]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[13]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[14]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[15]  Jean-François Dartigues,et al.  The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. , 2005, Brain : a journal of neurology.

[16]  L. Danober,et al.  Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice , 2003, Neuroscience.

[17]  K. Davis,et al.  Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease , 2006, Neurology.

[18]  D. Blacker,et al.  The genetics of Alzheimer disease: current status and future prospects. , 1998, Archives of neurology.

[19]  W. Klein Synaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer’s disease , 2006, Alzheimer's & Dementia.

[20]  S. Riedel-Heller,et al.  Mild cognitive impairment , 2006, Neurology.

[21]  S. Filipek,et al.  Genetic aspects of Alzheimer's disease. , 2004, Acta neurobiologiae experimentalis.

[22]  J. Schneider,et al.  Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.

[23]  S. Riedel-Heller,et al.  Progression of mild cognitive impairment to dementia: a challenge to current thinking. , 2006, The British journal of psychiatry : the journal of mental science.

[24]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[25]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[26]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[27]  Arthur L. Benton,et al.  Differential behavioral effects in frontal lobe disease , 1968 .

[28]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[29]  J. Morrison,et al.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease , 2003, Neurology.

[30]  D. Bennett,et al.  Mild cognitive impairment in different functional domains and incident Alzheimer’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  E. Tangalos,et al.  Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.

[32]  Paul Edison,et al.  Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography study , 2006, Annals of neurology.

[33]  M. Viitanen,et al.  Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease , 2006, Neurology.

[34]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.

[35]  C. Rowe,et al.  Imaging β-amyloid burden in aging and dementia , 2007, Neurology.

[36]  H. Engler,et al.  Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. , 2006, Brain : a journal of neurology.

[37]  H. Engler,et al.  PET imaging of amyloid deposition in patients with mild cognitive impairment , 2008, Neurobiology of Aging.

[38]  J. Schneider,et al.  Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. , 2004, Archives of neurology.

[39]  P. Maruff,et al.  Mild memory impairment in healthy older adults is distinct from normal aging , 2006, Brain and Cognition.

[40]  William E. Klunk,et al.  The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component , 2003, The Journal of Neuroscience.

[41]  Colin L Masters,et al.  Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. , 2006, Brain : a journal of neurology.

[42]  Yvette I. Sheline,et al.  Potential antecedent marker of Alzheimer disease , 2006 .

[43]  Charles D. Smith,et al.  Neuropathologic substrate of mild cognitive impairment. , 2006, Archives of neurology.

[44]  P. Agostinho,et al.  Susceptibility of hippocampal neurons to Aβ peptide toxicity is associated with perturbation of Ca2+ homeostasis , 2007, Brain Research.

[45]  S. DeKosky,et al.  Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  G Ratcliff,et al.  Normative Data on the Boston Naming Test and Two Equivalent 30-Item Short Forms , 2000, The Clinical neuropsychologist.

[47]  J. Morris,et al.  Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.

[48]  Nick C Fox,et al.  Amyloid, hypometabolism, and cognition in Alzheimer disease , 2007, Neurology.

[49]  S. M. Sumi,et al.  The Mean Aβ Load in the Hippocampus Correlates with Duration and Severity of Dementia in Subgroups of Alzheimer Disease , 1997, Journal of Neuropathology and Experimental Neurology.

[50]  A. Smith,et al.  Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. , 1996, Dementia.